Literature DB >> 6235285

Alterations in Fc receptor function of macrophages from streptozotocin-induced diabetic rats.

C K Abrass, M Hori.   

Abstract

The presence of elevated levels of circulating immune complexes in diabetic humans and animals suggests impaired phagocyte function. To evaluate FcR-mediated phagocytosis, resident peritoneal macrophages were harvested from control, streptozotocin-induced diabetic, and insulin-treated diabetic rats. FcR number and avidity were determined from Scatchard analysis of binding of 125I-labeled aggregated rat IgG (ARG) to macrophages. The total and fractional catabolic capacity were determined by quantitating the digestion of ARG as a percent of the total ARG added and as a percent of ARG bound. Insulin-deficient diabetic rats had an increase in the number of FcR per cell (26.8 +/- 3.5 X 10(4)) as compared with control animals (13.1 +/- 1.2 X 10(4)) (p less than 0.01). In contrast, insulin-treated diabetic animals had a reduction in the number of FcR per cell (9.8 +/- 1.4 X 10(4)) (p less than 0.01). FcR of macrophages from insulin-deficient diabetic rats had a lower avidity (Kd = 6.9 +/- 1.8 X 10(-10)M) when compared with control (3.7 +/- 0.6 X 10(-10)M) and insulin-treated diabetic rats (3.6 +/- 0.9 X 10(-10)M) (p less than 0.01). Total catabolism of ARG by macrophages from both insulin-deficient and insulin-treated diabetic rats was reduced (31.0% +/- 3.4 and 17.5% +/- 3, respectively) when compared with controls (49.6% +/- 5.2) (p less than 0.01). Fractional catabolism by macrophages from insulin-deficient diabetic rats was significantly reduced (21% +/- 1.9 and 4.6% +/- 0.9/10(4) FcR) when compared with results from control rats (26% +/- 1.3 and 6.7% +/- 0.7/10(4) FcR) (p less than 0.01), whereas the results from insulin-treated diabetic rats (32% +/- 2.4 and 10.8% +/- 1.0/10(4) FcR) (p less than 0.01) were greater than those from controls. These studies demonstrate that FcR-mediated phagocytosis of soluble, "model" immune complexes is impaired in macrophages from both insulin-deficient and insulin-treated diabetic rats; however, different mechanisms account for this impairment in phagocytosis. Despite an increase in FcR number of macrophages from insulin-deficient diabetic rats, the depression of post-receptor-mediated catabolism results in a net depression in phagocytic activity. In contrast, macrophages from insulin-treated diabetic rats display augmented post-receptor-mediated catabolism; however, this does not overcome the low initial binding of ARG to the cell that results from the depression of FcR number.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235285

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Proresolving lipid mediators and diabetic wound healing.

Authors:  Jason Hellmann; Yunan Tang; Matthew Spite
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-04       Impact factor: 3.243

2.  Measurement of the rates of basal pinocytosis of horseradish peroxidase and internalization of heat-aggregated IgG by macrophages from normal and streptozotocin-induced diabetic rats.

Authors:  C K Abrass
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

3.  Macrophage/monocyte receptor for nonenzymatically glycosylated protein is upregulated by cachectin/tumor necrosis factor.

Authors:  H Vlassara; L Moldawer; B Chan
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice.

Authors:  Savita Khanna; Sabyasachi Biswas; Yingli Shang; Eric Collard; Ali Azad; Courtney Kauh; Vineet Bhasker; Gayle M Gordillo; Chandan K Sen; Sashwati Roy
Journal:  PLoS One       Date:  2010-03-04       Impact factor: 3.240

Review 5.  Resolvins, specialized proresolving lipid mediators, and their potential roles in metabolic diseases.

Authors:  Matthew Spite; Joan Clària; Charles N Serhan
Journal:  Cell Metab       Date:  2013-11-14       Impact factor: 27.287

6.  Characterization of Stress and Innate Immunity Resistance of Wild-Type and Δp66 Borrelia burgdorferi.

Authors:  Michael W Curtis; Beth L Hahn; Kai Zhang; Chunhao Li; Richard T Robinson; Jenifer Coburn
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

7.  Blood-stage malaria infection in diabetic mice.

Authors:  K Elased; J B De Souza; J H Playfair
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

8.  Alterations in plasma clearance and tissue localization of model immune complexes in rats with streptozotocin-induced diabetes.

Authors:  C K Abrass; M T Hori
Journal:  Immunology       Date:  1987-03       Impact factor: 7.397

9.  Increased saturated fatty acids in obesity alter resolution of inflammation in part by stimulating prostaglandin production.

Authors:  Jason Hellmann; Michael J Zhang; Yunan Tang; Madhavi Rane; Aruni Bhatnagar; Matthew Spite
Journal:  J Immunol       Date:  2013-06-19       Impact factor: 5.422

Review 10.  Arachidonic Acid Metabolites in Cardiovascular and Metabolic Diseases.

Authors:  Thomas Sonnweber; Alex Pizzini; Manfred Nairz; Günter Weiss; Ivan Tancevski
Journal:  Int J Mol Sci       Date:  2018-10-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.